Global Health Clinics (TSE:MJRX)
:MJRX
Want to see TSE:MJRX full AI Analyst Report?
Top Page
Global Health Clinics
(MJRX)
Select Model
Select Model
Rating:43Neutral
Price Target:
C$0.04
▲(115.00% Upside)
Action:ReiteratedDate:04/28/26
The score is primarily dragged down by very weak financial performance (shrinking revenue, negative gross profit, persistent losses, cash burn, and negative equity with rising debt). Technicals are only modestly supportive with mixed trend signals and neutral RSI, while valuation metrics provide little support due to losses and no dividend yield.
Positive Factors
Modest absolute debt in earlier years
Historically modest absolute debt reduces legacy interest burden and gives the company structural flexibility relative to heavily leveraged peers. If management can stabilize operations, the lower historical debt base eases potential restructuring or refinancing needs and limits immediate solvency pressure.
Negative Factors
Consistently negative shareholders' equity
Persistent negative equity is a structural solvency concern: it constrains access to capital, makes traditional lending difficult, and raises the likelihood of dilution or distressed recapitalization. This undermines long‑term financial flexibility and raises execution risk for strategic initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Modest absolute debt in earlier years
Historically modest absolute debt reduces legacy interest burden and gives the company structural flexibility relative to heavily leveraged peers. If management can stabilize operations, the lower historical debt base eases potential restructuring or refinancing needs and limits immediate solvency pressure.
Read all positive factors
Global Health Clinics (MJRX) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$422.65K
Dividend YieldN/A
Average Volume (3M)7.79K
Price to Earnings (P/E)―
Beta (1Y)-1.45
Revenue Growth-74.95%
EPS Growth-13.64%
CountryCA
EmployeesN/A
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.04
Shares Outstanding9,392,138
10 Day Avg. Volume900
30 Day Avg. Volume7,790
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.02
Price to Sales (P/S)1.97
P/FCF Ratio-0.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Global Health Clinics Business Overview & Revenue Model
Company Description
Global Health Clinics Ltd. operates in the cannabis industry. The company operates medical clinics, which guide patients through the process of becoming legal users of marijuana. It also engages in developing psilocybin products for research and u...
How the Company Makes Money
null...
Global Health Clinics Financial Statement Overview
Summary
Income Statement
7
Very Negative
Balance Sheet
5
Very Negative
Cash Flow
10
Very Negative
| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.68K | 47.77K | 82.96K | 102.85K | 146.81K | 225.09K |
| Gross Profit | -271.74K | -515.73K | 63.88K | 80.64K | 116.00K | 177.75K |
| EBITDA | -1.08M | -1.05M | -947.00K | -1.57M | -1.35M | -8.34M |
| Net Income | -1.34M | -1.27M | -1.08M | -1.63M | -1.37M | -8.48M |
Balance Sheet | ||||||
| Total Assets | 52.88K | 66.14K | 29.33K | 241.50K | 578.81K | 610.60K |
| Cash, Cash Equivalents and Short-Term Investments | 43.85K | 50.48K | 9.19K | 214.34K | 496.69K | 456.26K |
| Total Debt | 2.78M | 1.91M | 1.52M | 1.10M | 322.31K | 30.81K |
| Total Liabilities | 5.25M | 4.59M | 3.29M | 2.43M | 1.14M | 1.05M |
| Stockholders Equity | -5.20M | -4.53M | -3.26M | -2.18M | -559.58K | -440.39K |
Cash Flow | ||||||
| Free Cash Flow | -596.25K | -572.21K | -496.55K | -1.01M | -1.49M | -825.80K |
| Operating Cash Flow | -596.25K | -572.21K | -496.55K | -1.01M | -1.49M | -825.80K |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 428.97K |
| Financing Cash Flow | 601.07K | 613.50K | 291.40K | 727.48K | 1.53M | 763.22K |
Global Health Clinics Technical Analysis
Negative
0.02
Price Trends
0.05
Negative
0.04
Negative
0.03
Positive
Market Momentum
>-0.01
Positive
17.42
Positive
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MJRX, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 17.42 is Positive, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:MJRX.
Global Health Clinics Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | C$2.61B | 16.23 | 6.29% | ― | 5.40% | 62.80% | |
67 Neutral | C$2.50B | -13.95 | -9.71% | ― | 1.59% | 29.84% | |
58 Neutral | C$3.63B | -8.05 | -28.58% | ― | -2.90% | -4.82% | |
58 Neutral | C$912.74M | -9.05 | -10.60% | 3.56% | 4.34% | -1767.51% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | C$2.17B | -1.75 | -30.10% | ― | -4.56% | 25.73% | |
43 Neutral | C$422.65K | -0.24 | ― | ― | -74.95% | -13.64% |
* Healthcare Sector Average
TSE:MJRX
Global Health Clinics
0.05
0.03
350.00%
TSE:CURA
Curaleaf Holdings
4.53
3.03
202.00%
TSE:GTII
Green Thumb Industries
10.86
1.85
20.53%
TSE:TRUL
Trulieve Cannabis
13.69
6.89
101.32%
TSE:VRNO
Verano Holdings
6.32
0.00
0.00%
TSE:DHT.UN
DRI Healthcare
16.41
5.34
48.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.